UBS ASSET MANAGEMENT AMERICAS LLC - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 51 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$2,795,000
+17.5%
1,615,203
+5.3%
0.00%
+50.0%
Q3 2014$2,378,000
-3.8%
1,534,477
+41.5%
0.00%0.0%
Q2 2014$2,473,000
-17.5%
1,084,493
-2.0%
0.00%
-33.3%
Q1 2014$2,998,000
-24.8%
1,106,185
+22.6%
0.00%
-40.0%
Q4 2013$3,987,000
+411.8%
902,054
+423.5%
0.01%
+400.0%
Q3 2013$779,000
+42.2%
172,300
+77.8%
0.00%0.0%
Q2 2013$548,00096,9000.00%
Other shareholders

There were no reported owners of KALOBIOS PHARMACEUTICALS INC in Q3 2013.

NameSharesValueWeighting ↓
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders